ACET ▲ +11.5% - Adicet Bio, Inc. $ACET Adicet Bio Announces FDA Clearance of IND Application for ADI-212 Adicet Bio shares jumped 11.5% following the company's announcement that the FDA has cleared its Investigational New Drug application for ADI-212. The IND clearance allows the company to begin clinical testing of the candidate, representing a key regulatory milestone that enables advancement of the program toward potential human trials. 27-AUG-2026 04:00 PM ET